09-Jan-2024 | BC | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve 1. the Un-Audited Financial Stat | 29-Jan-2024 | |
16-Oct-2023 | BC | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve the Un-Audited Financial Statem | 27-Oct-2023 | |
27-Jul-2023 | BC | Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon.
Intimation of Book Closure Pursuant to the Regulation 42(2 | 25-Sep-2023 | |
27-Jul-2023 | BC | Annual General Meeting | 19-Sep-2023 | |
14-Jul-2023 | BC | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve 1. the Un-Audited Financial Resu | 27-Jul-2023 | |
No Dividends has been declared by CHEMOPHARMALABORATORIES
No Bonus has been declared by CHEMOPHARMALABORATORIES
No Split has been declared by CHEMOPHARMALABORATORIES
RightsNo Rights has been declared by CHEMOPHARMALABORATORIES
Book Closure
29-Jan-2024 | - | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve 1. the Un-Audited Financial Stat |
27-Oct-2023 | - | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve the Un-Audited Financial Statem |
25-Sep-2023 | - | Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon.
Intimation of Book Closure Pursuant to the Regulation 42(2 |
19-Sep-2023 | 01 Jan'1900 | Annual General Meeting |
27-Jul-2023 | - | CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve 1. the Un-Audited Financial Resu |